[{"symbol": "CHB", "assetClass": "Equity", "aum": 1407909, "avgVolume": 712, "cusip": "37954Y251", "description": "The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (\"ADRs\") and Global Depositary Receipts (\"GDRs\") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China\u2019s biotechnology industry. It is non-diversified.", "domicile": "US", "etfCompany": "Global X", "expenseRatio": 0.65, "inceptionDate": "2020-09-25", "isin": "US37954Y2515", "name": "Global X China Biotech Innovation ETF", "nav": 6.72, "navCurrency": "USD", "sectorsList": [{"industry": "Basic Materials", "exposure": 0.84}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 0}, {"industry": "Consumer Defensive", "exposure": 0}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 99.16}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 0}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "https://www.globalxetfs.com/funds/CHB", "holdingsCount": 2}]